Seeking Alpha

Dominic Rodrigues'  Instablog

Dominic Rodrigues
Send Message
Pursuing entrepreneurship through corporate development and investment management in industries like aerospace & defense, biotechnology, environmental management, financial services, information technology, and life sciences by raising, investing, developing and managing money across a range... More
My blog:
Connecting the dots...Provectus Biopharmaceuticals
  • Pole Position 0 comments
    Jul 24, 2012 12:29 AM | about stocks: PVCT, PFE

    Taken From Connecting The Dots...Provectus Pharmaceuticals (June 22, 2012).

    None of us can predict or foresee who will acquire Provectus (or, for that matter, who will do a mini-oncology or dermatology deal with the company). Well, maybe Eddie Morra knows. We can try to predict or we can think we're making educated guesses, but it's mostly speculation for now. Management's thoughts on this topic are key.

    Craig Eagle's presence on Provectus' corporate advisory board (NYSE:CAB) is an important data point. Executives within Big Pharma have different degrees of flexibility in their respective business mission, role and responsibilities. How many oncology-focused biotechnology companies have executives from Pfizer's Oncology Business Unit (OBU) associated with them in a formal or informal fashion? How many executives within OBU are associated with oncology-focused companies? For that matter, how about other Big Pharma?

    In a world where there are few drug in development that work and fewer still that work well, Big Pharma teams tasked with refilling drug pipelines (outside of internal R&D) keep their eyes on a short list of candidates. No one wants to be uninformed or late to the game when it comes to understanding who has a drug that works and works well. No one wants to be too far down in line when it comes times to act.

    Craig Eagle's extensive and germane experience clearly is a very big plus for Provectus to access and from which to benefit. It does strike me, however, that he occupies the pole position on behalf of Pfizer for when it comes time to act.

    Disclosure: I am long OTC:PVCT.

    Additional disclosure: I am a large shareholder of Provectus Pharmaceuticals. I have not sold any shares as of this Instablog submission.

    Themes: Biotechnology Stocks: PVCT, PFE
Back To Dominic Rodrigues' Instablog HomePage »

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

Comments (0)
Track new comments
Be the first to comment
Full index of posts »
Latest Followers

Latest Comments

Posts by Themes
Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.